<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Prescription Drugs</title>
	<atom:link href="http://www.prescriptiondrugs2go.com/feed" rel="self" type="application/rss+xml" />
	<link>http://www.prescriptiondrugs2go.com</link>
	<description>Popoular Prescription Drugs Latest News</description>
	<lastBuildDate>Fri, 03 Sep 2010 11:20:05 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Botox Whistleblower Case Settles for $600 Million</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-whistleblower-case-settles-for-600-million.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-whistleblower-case-settles-for-600-million.html#comments</comments>
		<pubDate>Fri, 03 Sep 2010 11:20:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Botox]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-whistleblower-case-settles-for-600-million.html</guid>
		<description><![CDATA[Pharmaceutical manufacturer Allergan, Inc. has agreed to pay $225 million to resolve civil allegations that it unlawfully promoted its drug Botox&#174; Therapeutic for unapproved uses and that it paid&#8230;(PRWeb September 01, 2010)Read the full story at http://www.prweb.com/releases/2010/09/prweb4455594.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Message: Register for MedMatcha, MedWorm&#8217;s medical advertising network, and receive $5 free advertising.

Botox Whistleblower Case Settles for $600 Million is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-whistleblower-case-settles-for-600-million.html">Botox Whistleblower Case Settles for $600 Million</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Pharmaceutical manufacturer Allergan, Inc. has agreed to pay $225 million to resolve civil allegations that it unlawfully promoted its drug <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox">Botox</a>&#174; Therapeutic for unapproved uses and that it paid&#8230;(PRWeb September 01, 2010)Read the full story at http://www.prweb.com/releases/2010/09/prweb4455594.htm (Source: PRWeb: Medical Pharmaceuticals)
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-whistleblower-case-settles-for-600-million.html">Botox Whistleblower Case Settles for $600 Million</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-whistleblower-case-settles-for-600-million.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Botox maker to pay $600M to resolve U.S. probe</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-maker-to-pay-600m-to-resolve-u-s-probe.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-maker-to-pay-600m-to-resolve-u-s-probe.html#comments</comments>
		<pubDate>Fri, 03 Sep 2010 11:20:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Botox]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-maker-to-pay-600m-to-resolve-u-s-probe.html</guid>
		<description><![CDATA[Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug. (Source: CTV Health)
Botox maker to pay $600M to resolve U.S. probe is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-maker-to-pay-600m-to-resolve-u-s-probe.html">Botox maker to pay $600M to resolve U.S. probe</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Allergan Inc., the maker of wrinkle-smoothing <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox">Botox</a>, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug. (Source: CTV Health)</p>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-maker-to-pay-600m-to-resolve-u-s-probe.html">Botox maker to pay $600M to resolve U.S. probe</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-maker-to-pay-600m-to-resolve-u-s-probe.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Botox Maker To Pay $600M In Resolution</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-maker-to-pay-600m-in-resolution.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-maker-to-pay-600m-in-resolution.html#comments</comments>
		<pubDate>Fri, 03 Sep 2010 11:20:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Botox]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-maker-to-pay-600m-in-resolution.html</guid>
		<description><![CDATA[Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a long federal investigation into its marketing of the top-selling, botulin-based drug. (Source: WDSU.com &#8211; Health)
Botox Maker To Pay $600M In Resolution is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-maker-to-pay-600m-in-resolution.html">Botox Maker To Pay $600M In Resolution</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Allergan Inc., the maker of wrinkle-smoothing <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox">Botox</a>, has agreed to pay $600 million to settle a long federal investigation into its marketing of the top-selling, botulin-based drug. (Source: WDSU.com &#8211; Health)</p>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-maker-to-pay-600m-in-resolution.html">Botox Maker To Pay $600M In Resolution</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/b/botox/botox-maker-to-pay-600m-in-resolution.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATEcapsule [Bryant Ranch Prepack]</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/b/butalbital/butalbital-aspirin-caffeine-and-codeine-phosphatecapsule-bryant-ranch-prepack.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/b/butalbital/butalbital-aspirin-caffeine-and-codeine-phosphatecapsule-bryant-ranch-prepack.html#comments</comments>
		<pubDate>Fri, 03 Sep 2010 06:40:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Butalbital]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/b/butalbital/butalbital-aspirin-caffeine-and-codeine-phosphatecapsule-bryant-ranch-prepack.html</guid>
		<description><![CDATA[Updated Date: Sep 1, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

MedWorm Message: Register for MedMatcha, MedWorm&#8217;s medical advertising network, and receive $5 free advertising.

BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATEcapsule [Bryant Ranch Prepack] is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/butalbital/butalbital-aspirin-caffeine-and-codeine-phosphatecapsule-bryant-ranch-prepack.html">BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATEcapsule [Bryant Ranch Prepack]</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Updated Date: Sep 1, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/butalbital/butalbital-aspirin-caffeine-and-codeine-phosphatecapsule-bryant-ranch-prepack.html">BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATEcapsule [Bryant Ranch Prepack]</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/b/butalbital/butalbital-aspirin-caffeine-and-codeine-phosphatecapsule-bryant-ranch-prepack.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BUPROPION HYDROCHLORIDEtablet, Extended Release [Sandoz Inc.]</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/b/bupropion/bupropion-hydrochloridetablet-extended-release-sandoz-inc-2.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/b/bupropion/bupropion-hydrochloridetablet-extended-release-sandoz-inc-2.html#comments</comments>
		<pubDate>Fri, 03 Sep 2010 05:40:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bupropion]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/b/bupropion/bupropion-hydrochloridetablet-extended-release-sandoz-inc-2.html</guid>
		<description><![CDATA[Updated Date: Sep 1, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

MedWorm Message: Register for MedMatcha, MedWorm&#8217;s medical advertising network, and receive $5 free advertising.

BUPROPION HYDROCHLORIDEtablet, Extended Release [Sandoz Inc.] is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/bupropion/bupropion-hydrochloridetablet-extended-release-sandoz-inc-2.html">BUPROPION HYDROCHLORIDEtablet, Extended Release [Sandoz Inc.]</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Updated Date: Sep 1, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/bupropion/bupropion-hydrochloridetablet-extended-release-sandoz-inc-2.html">BUPROPION HYDROCHLORIDEtablet, Extended Release [Sandoz Inc.]</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/b/bupropion/bupropion-hydrochloridetablet-extended-release-sandoz-inc-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BUPROPION HYDROCHLORIDEtablet, Extended Release [NCS HealthCare Of KY, Inc Dba Vangard Labs]</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/b/bupropion/bupropion-hydrochloridetablet-extended-release-ncs-healthcare-of-ky-inc-dba-vangard-labs.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/b/bupropion/bupropion-hydrochloridetablet-extended-release-ncs-healthcare-of-ky-inc-dba-vangard-labs.html#comments</comments>
		<pubDate>Fri, 03 Sep 2010 05:40:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bupropion]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/b/bupropion/bupropion-hydrochloridetablet-extended-release-ncs-healthcare-of-ky-inc-dba-vangard-labs.html</guid>
		<description><![CDATA[Updated Date: Sep 1, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
BUPROPION HYDROCHLORIDEtablet, Extended Release [NCS HealthCare Of KY, Inc Dba Vangard Labs] is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/bupropion/bupropion-hydrochloridetablet-extended-release-ncs-healthcare-of-ky-inc-dba-vangard-labs.html">BUPROPION HYDROCHLORIDEtablet, Extended Release [NCS HealthCare Of KY, Inc Dba Vangard Labs]</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Updated Date: Sep 1, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</p>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/bupropion/bupropion-hydrochloridetablet-extended-release-ncs-healthcare-of-ky-inc-dba-vangard-labs.html">BUPROPION HYDROCHLORIDEtablet, Extended Release [NCS HealthCare Of KY, Inc Dba Vangard Labs]</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/b/bupropion/bupropion-hydrochloridetablet-extended-release-ncs-healthcare-of-ky-inc-dba-vangard-labs.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/caspofungin/safety-and-pharmacokinetics-of-higher-doses-of-caspofungin-in-healthy-adult-participants-3.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/caspofungin/safety-and-pharmacokinetics-of-higher-doses-of-caspofungin-in-healthy-adult-participants-3.html#comments</comments>
		<pubDate>Fri, 03 Sep 2010 03:20:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Caspofungin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/caspofungin/safety-and-pharmacokinetics-of-higher-doses-of-caspofungin-in-healthy-adult-participants-3.html</guid>
		<description><![CDATA[Migoya E, Mistry GC, Stone JA, Comisar W, Sun P, Norcross A, Bi S, Winchell GA, Ghosh K, Uemera N, Deutsch PJ, Wagner JA (Source: The Aspergillus Website &#8211; articles)
Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/caspofungin/safety-and-pharmacokinetics-of-higher-doses-of-caspofungin-in-healthy-adult-participants-3.html">Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Migoya E, Mistry GC, Stone JA, Comisar W, Sun P, Norcross A, Bi S, Winchell GA, Ghosh K, Uemera N, Deutsch PJ, Wagner JA (Source: The Aspergillus Website &#8211; articles)</p>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/caspofungin/safety-and-pharmacokinetics-of-higher-doses-of-caspofungin-in-healthy-adult-participants-3.html">Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/caspofungin/safety-and-pharmacokinetics-of-higher-doses-of-caspofungin-in-healthy-adult-participants-3.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BENAZEPRIL HYDROCHLORIDEtablet, Film Coated [Huahai US Inc]</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/b/benazepril/benazepril-hydrochloridetablet-film-coated-huahai-us-inc.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/b/benazepril/benazepril-hydrochloridetablet-film-coated-huahai-us-inc.html#comments</comments>
		<pubDate>Fri, 03 Sep 2010 03:20:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Benazepril]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/b/benazepril/benazepril-hydrochloridetablet-film-coated-huahai-us-inc.html</guid>
		<description><![CDATA[Updated Date: Sep 1, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

MedWorm Message: Register for MedMatcha, MedWorm&#8217;s medical advertising network, and receive $5 free advertising.

BENAZEPRIL HYDROCHLORIDEtablet, Film Coated [Huahai US Inc] is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/benazepril/benazepril-hydrochloridetablet-film-coated-huahai-us-inc.html">BENAZEPRIL HYDROCHLORIDEtablet, Film Coated [Huahai US Inc]</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Updated Date: Sep 1, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/benazepril/benazepril-hydrochloridetablet-film-coated-huahai-us-inc.html">BENAZEPRIL HYDROCHLORIDEtablet, Film Coated [Huahai US Inc]</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/b/benazepril/benazepril-hydrochloridetablet-film-coated-huahai-us-inc.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Review: Procedure- and Device-Related Complications of Intrathecal Baclofen Administration for Management of Adult Muscle Hypertonia: A Review</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/b/baclofen/review-procedure-and-device-related-complications-of-intrathecal-baclofen-administration-for-management-of-adult-muscle-hypertonia-a-review.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/b/baclofen/review-procedure-and-device-related-complications-of-intrathecal-baclofen-administration-for-management-of-adult-muscle-hypertonia-a-review.html#comments</comments>
		<pubDate>Fri, 03 Sep 2010 03:01:14 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Baclofen]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/b/baclofen/review-procedure-and-device-related-complications-of-intrathecal-baclofen-administration-for-management-of-adult-muscle-hypertonia-a-review.html</guid>
		<description><![CDATA[Conclusions. Catheter problems are relatively common and more frequent than pump or surgical procedure complications after ITB pump implantation. Higher complication rates should be expected in centers that follow patients for a longer period of time. Standardized data collection and complication-reporting procedures along with appropriate training should be implemented in centers offering ITB treatment for management of muscle hypertonia. (Source: Neurorehabilitation and Neural Repair)

MedWorm Message: Register for MedMatcha, MedWorm&#8217;s medical advertising network, and receive $5 free advertising.

Review: Procedure- and Device-Related Complications of Intrathecal Baclofen Administration for Management of Adult Muscle ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/baclofen/review-procedure-and-device-related-complications-of-intrathecal-baclofen-administration-for-management-of-adult-muscle-hypertonia-a-review.html">Review: Procedure- and Device-Related Complications of Intrathecal Baclofen Administration for Management of Adult Muscle Hypertonia: A Review</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Conclusions. Catheter problems are relatively common and more frequent than pump or surgical procedure complications after ITB pump implantation. Higher complication rates should be expected in centers that follow patients for a longer period of time. Standardized data collection and complication-reporting procedures along with appropriate training should be implemented in centers offering ITB treatment for management of muscle hypertonia. (Source: Neurorehabilitation and Neural Repair)
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/b/baclofen/review-procedure-and-device-related-complications-of-intrathecal-baclofen-administration-for-management-of-adult-muscle-hypertonia-a-review.html">Review: Procedure- and Device-Related Complications of Intrathecal Baclofen Administration for Management of Adult Muscle Hypertonia: A Review</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/b/baclofen/review-procedure-and-device-related-complications-of-intrathecal-baclofen-administration-for-management-of-adult-muscle-hypertonia-a-review.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Antivirals for influenza: strategies for use in pediatrics.</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/a/antivirals-for-influenza-strategies-for-use-in-pediatrics.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/a/antivirals-for-influenza-strategies-for-use-in-pediatrics.html#comments</comments>
		<pubDate>Fri, 03 Sep 2010 03:01:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[A]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/a/antivirals-for-influenza-strategies-for-use-in-pediatrics.html</guid>
		<description><![CDATA[Authors: Smith SM, Gums JG
    Influenza infection is annually responsible for significant morbidity and mortality, particularly among the very young and old. Recently updated guidelines recommend influenza vaccination of all children aged 6 months to 18 years; however, childhood vaccination remains underutilized. Furthermore, concerns over the reduced efficacy of vaccination in children have further heightened the need for effective treatment schemes. Antiviral therapies have emerged as attractive options in the battle against influenza infection. These agents include the adamantanes (amantadine and rimantadine) and neuraminidase inhibitors (zanamivir, oseltamivir, ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/a/antivirals-for-influenza-strategies-for-use-in-pediatrics.html">Antivirals for influenza: strategies for use in pediatrics.</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Authors: Smith SM, Gums JG<br />
    Influenza infection is annually responsible for significant morbidity and mortality, particularly among the very young and old. Recently updated guidelines recommend influenza vaccination of all children aged 6 months to 18 years; however, childhood vaccination remains underutilized. Furthermore, concerns over the reduced efficacy of vaccination in children have further heightened the need for effective treatment schemes. Antiviral therapies have emerged as attractive options in the battle against influenza infection. These agents include the adamantanes (amantadine and rimantadine) and neuraminidase inhibitors (zanamivir, oseltamivir, and peramivir). Broad-scale use of adamantane antivirals has been severely limited in recent years because of high resistance&#8230;
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/a/antivirals-for-influenza-strategies-for-use-in-pediatrics.html">Antivirals for influenza: strategies for use in pediatrics.</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/a/antivirals-for-influenza-strategies-for-use-in-pediatrics.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
